Association of the Timing of Pregnancy With Survival in Women With Breast Cancer
- PMID: 28278319
- PMCID: PMC5824205
- DOI: 10.1001/jamaoncol.2017.0248
Association of the Timing of Pregnancy With Survival in Women With Breast Cancer
Abstract
Importance: Increasing numbers of women experience pregnancy around the time of, or after, a diagnosis of breast cancer. Understanding the effect of pregnancy on survival in women with breast cancer will help in the counseling and treatment of these women.
Objective: To compare the overall survival of women diagnosed with breast cancer during pregnancy or in the postpartum period with that of women who had breast cancer but did not become pregnant.
Design, setting, and participants: This population-based, retrospective cohort study linked health administrative databases in Ontario, Canada, comprising 7553 women aged 20 to 45 years at the time of diagnosis with invasive breast cancer, from January 1, 2003, to December 31, 2014.
Exposures: Any pregnancy in the period from 5 years before, until 5 years after, the index date of the diagnosis of breast cancer. Women were classified into the following 4 exposure groups: no pregnancy (the referent), pregnancy before breast cancer, pregnancy-associated breast cancer, and pregnancy following breast cancer.
Main outcomes and measures: Five-year actuarial survival rates for all exposure groups, age-adjusted and multivariable hazard ratios [HRs] of pregnancy for overall survival for all exposure groups, and time-dependent hazard ratios for women with pregnancy following breast cancer.
Results: Among the 7553 women in the study (mean age at diagnosis, 39.1 years; median, 40 years; range, 20-44 years) the 5-year actuarial survival rate was 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy, 85.3% (95% CI, 82.8%-87.8%) for women with pregnancy before breast cancer (age-adjusted hazard ratio, 1.03; 95% CI, 0.85-1.27; P = .73), and 82.1% (95% CI, 78.3%-85.9%) for women with pregnancy-associated breast cancer (age-adjusted hazard ratio, 1.18; 95% CI, 0.91-1.53; P = .20). The 5-year actuarial survival rate was 96.7% (95% CI, 94.1%-99.3%) for women who had pregnancy 6 months or more after diagnosis of breast cancer, vs 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy) (age-adjusted HR, 0.22; 95% CI, 0.10-0.49; P < .001).
Conclusions and relevance: Pregnancy did not adversely affect survival in women with breast cancer. For breast cancer survivors who wish to conceive, the risk of death is lowest if pregnancy occurs 6 months or more after diagnosis.
Conflict of interest statement
Figures

Comment in
-
Timing of Pregnancy and Survival in Women With Breast Cancer.JAMA Oncol. 2018 Jan 1;4(1):131. doi: 10.1001/jamaoncol.2017.2711. JAMA Oncol. 2018. PMID: 28880981 No abstract available.
Similar articles
-
Association of pregnancy and mortality in women diagnosed with breast cancer: A Nationwide Population Based Study in Taiwan.Int J Cancer. 2018 Nov 15;143(10):2416-2424. doi: 10.1002/ijc.31777. Epub 2018 Sep 21. Int J Cancer. 2018. PMID: 30070358
-
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study.J Clin Oncol. 2013 Jul 10;31(20):2532-9. doi: 10.1200/JCO.2012.45.6335. Epub 2013 Apr 22. J Clin Oncol. 2013. PMID: 23610117
-
Maternal survival of patients with pregnancy-associated cancers in Taiwan - A national population-based study.Cancer Med. 2020 Dec;9(24):9431-9444. doi: 10.1002/cam4.3565. Epub 2020 Oct 25. Cancer Med. 2020. PMID: 33099894 Free PMC article.
-
Prognosis of pregnancy-associated breast cancer: a meta-analysis.BMC Cancer. 2020 Aug 10;20(1):746. doi: 10.1186/s12885-020-07248-8. BMC Cancer. 2020. PMID: 32778072 Free PMC article.
-
Pregnancy-associated breast cancer.Semin Surg Oncol. 1991 Sep-Oct;7(5):306-10. doi: 10.1002/ssu.2980070514. Semin Surg Oncol. 1991. PMID: 1775817 Review.
Cited by
-
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.Breast Cancer Res Treat. 2020 May;181(1):77-86. doi: 10.1007/s10549-020-05598-2. Epub 2020 Mar 31. Breast Cancer Res Treat. 2020. PMID: 32236826 Free PMC article.
-
Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale.Int J Gynecol Cancer. 2023 May 1;33(5):778-785. doi: 10.1136/ijgc-2023-004302. Int J Gynecol Cancer. 2023. PMID: 37001892 Free PMC article.
-
No increased risk of relapse of breast cancer for women who give birth after assisted conception.Hum Reprod Open. 2019 Dec 18;2019(4):hoz039. doi: 10.1093/hropen/hoz039. eCollection 2019. Hum Reprod Open. 2019. PMID: 31872070 Free PMC article.
-
Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study.Cancer Res Treat. 2020 Apr;52(2):426-437. doi: 10.4143/crt.2018.382. Epub 2019 Sep 3. Cancer Res Treat. 2020. PMID: 31476846 Free PMC article.
-
Countercurrents: The bias of choice.Curr Oncol. 2019 Dec;26(6):e712-e713. doi: 10.3747/co.26.5165. Epub 2019 Dec 1. Curr Oncol. 2019. PMID: 31896940 Free PMC article. No abstract available.
References
-
- Surveillance, Epidemiology, and End Results Program, National Cancer Institute SEER cancer statistics review (CSR) 1975-2013. http://seer.cancer.gov/csr/1975_2013/. Updated September 12, 2016. Accessed February 8, 2017.
-
- Milan A. Report on the demographic situation in Canada (91-209-X). http://www5.statcan.gc.ca/olc-cel/olc.action?ObjId=91-209-X&ObjType=2&la.... Accessed October 5, 2016.
-
- Middleton LP, Chen V, Perkins GH, Pinn V, Page D. Histopathology of breast cancer among African-American women. Cancer. 2003;97(1)(suppl):253-257. - PubMed
-
- Gentilini O, Cremonesi M, Trifirò G, et al. . Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15(9):1348-1351. - PubMed
-
- Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R. Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast. 2012;21(4):550-555. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical